Altium Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-180,000
| Closed | -$4.18M | – | 82 |
|
|
2023
Q1 | $4.18M | Sell |
180,000
-32,000
| -15% | -$743K | 2.32% | 12 |
|
|
2022
Q4 | $3.08M | Buy |
212,000
+26,000
| +14% | +$377K | 1.56% | 24 |
|
|
2022
Q3 | $3.55M | Sell |
186,000
-35,000
| -16% | -$668K | 1.3% | 29 |
|
|
2022
Q2 | $4.02M | Buy |
221,000
+106,290
| +93% | +$1.93M | 1.61% | 16 |
|
|
2022
Q1 | $2.89M | Sell |
114,710
-75,290
| -40% | -$1.9M | 0.97% | 38 |
|
|
2021
Q4 | $5.24M | Buy |
190,000
+32,000
| +20% | +$883K | 1.45% | 20 |
|
|
2021
Q3 | $5.1M | Sell |
158,000
-13,242
| -8% | -$428K | 1.34% | 26 |
|
|
2021
Q2 | $5.24M | Sell |
171,242
-543
| -0.3% | -$16.6K | 1.21% | 25 |
|
|
2021
Q1 | $5.23M | Sell |
171,785
-46,865
| -21% | -$1.43M | 1.45% | 21 |
|
|
2020
Q4 | $4.32M | Buy |
+218,650
| New | +$4.32M | 1.61% | 17 |
|